¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"administration, cutaneous"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cutaneous basophil hypersensitivity
    ÇǺÎÈ£¿°±¸°ú¹Î(Áõ)
  • cutaneous drug reaction
    ÇǺξ๰¹ÝÀÀ
  • cutaneous gangrene
    ÇǺα«Àú
  • cutaneous habronemiasis
    ÇǺÎÇϺê·Î³×¸¶Áõ
  • cutaneous hallucination
    ÇǺÎȯ°¢
  • cutaneous helminthiasis
    ÇǺο¬ÃæÁõ
  • cutaneous horn
    ÇǺλÔ
  • cutaneous larva migrans
    ÇǺξֹú·¹ÀÌÇàÁõ, ÇǺÎÀ¯ÃæÀÌÇàÁõ
  • cutaneous leishmaniasis
    ÇǺθ®½´¸¸Æí¸ðÃæÁõ
  • cutaneous lymphoid hyperplasia
    ÇǺθ²ÇÁ°ú´ÙÇü¼º
  • cutaneous mucosal hyalinosis
    ÇǺÎÁ¡¸·À¯¸®ÁúÁõ
  • cutaneous necrotizing venulitis
    ÇǺα«»ç¼¼Á¤¸Æ¿°
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • cutaneous nerve
    ÇǺνŰæ
  • cutaneous nerve ending
    ÇǺνŰæÁ¾¸»
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • cutaneous
    ÇǺÎ-
  • cutaneous larva migrans
    ÇǺξֹú·¹ÀÌÇàÁõ, ÇǺÎÀ¯ÃæÀÌÇàÁõ
  • cutaneous disorder
    ÇǺÎÁúȯ
  • cutaneous endometriosis
    Ç¥ÀçÀڱ󻸷Áõ, Ç¥¸éÀڱ󻸷Áõ
  • cutaneous gangrene
    ÇǺα«Àú
  • cutaneous habronemiasis
    ÇǺÎÇϺê·Î³×¸¶Áõ
  • cutaneous hallucination
    ÇǺÎȯ°¢
  • cutaneous helminthiasis
    ÇǺο¬ÃæÁõ
  • cutaneous horn
    ÇǺλÔ
  • cutaneous leishmaniasis
    ÇǺθ®½´¸¸Æí¸ðÃæÁõ
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • cutaneous nerve
    ÇǺνŰæ
  • cutaneous reaction
    ÇǺιÝÀÀ
  • cutaneous ridge
    ÇǺδɼ±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anterior cutaneous branches
    ¾ÕÇǺΰ¡Áö
  • graft, perichondral cutaneous
    ¿¬°ñ¸·ÇǺÎÀ̽Ä
  • hallucination, cutaneous
    ÇǺÎȯ°¢(ù«Ý±ü³ÊÆ)
  • inferior lateral cutaneous nerve of arm
    ¾Æ·¡°¡ÂÊÀ§ÆÈÇǺνŰæ
  • posterior cutaneous branch
    µÚÇǺΰ¡Áö
  • posterior cutaneous nerve of arm
    µÚÀ§ÆÈÇǺνŰæ
  • posterior cutaneous nerve of forearm
    µÚ¾Æ·¡ÆÈÇǺνŰæ
  • posterior femoral cutaneous nerve
    µÚ³Ò´Ù¸®ÇǺνŰæ
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary localized cutaneous amyloidosis
    ¿ø¹ß¼º ±¹¼Ò ÇǺΠÀ¯ÀüºÐÁõ
  • random cutaneous flap
    ÀÓÀÇÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prolonged administration
    Àå±âÅõ¿©.
  • public health administration
    °øÁߺ¸°ÇÇàÁ¤ (ÊÙÌ´Ëø).
  • rural health administration
    ³óÃ̺¸°ÇÇàÁ¤(ËÀ̧ËÓË§Ì´Ëø).
  • subcutaneous administration
    ÇÇÇÏÅõ¿©(ù«ù»÷áæ¨).
  • transdermal administration
    °æÇÇÅõ¿©.
  • urgent administration
    ±ä±ÞÀû¿ë(ÑÌÐáîêéÄ).
  • welfare administration
    º¹ÁöÇàÁ¤(ÊÙÌ´Ëø).
  • american cutaneous leishmaniasis
    ¾Æ¸Þ¸®Ä«ÇǺθ®½´¸¶´Ï¾Æº´
  • anterior cutaneous branch
    ¾ÕÇǺΰ¡Áö
  • anterior cutaneous branch (of abdomen)
    ¾Õ(¹è)ÇǺΰ¡Áö
  • anterior cutaneous branch (of thorax)
    ¾Õ(°¡½¿)ÇǺΰ¡Áö
  • anterior cutaneous branches
    ¾ÕÇǺΰ¡Áö
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺΰüÀý ÁõÈıº
  • cutaneous
    ÇǺÎ(ù«Ý±)ÀÇ
  • cutaneous B cell lymphoma
    ÇǺΠB¼¼Æ÷¸²ÇÁÁ¾
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Medial cutaneous nerve of arm
    ¾ÈÂÊÀ§ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ³»Ãø»ó¿ÏÇǽŰæ
  • Medial sural cutaneous nerve
    ¾ÈÂÊÀåµýÁöÇǺνŰæ
    [¿¾ ¿ë¾î] ³»Ãøºñº¹ÇǽŰæ
  • Medial cutaneous branches of leg
    ¾ÈÂÊÁ¾¾Æ¸®ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ³»ÃøÇÏÅðÇÇÁö
  • Medial cutaneous branch
    ¾ÈÂÊÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ³»ÃøÇÇÁö
  • Anterior cutaneous branch (of thorax)
    ¾Õ(°¡½¿)ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] Àü(Èä)ÇÇÁö
  • Anterior cutaneous branch (of abdomen)
    ¾Õ(¹è)ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] Àü(º¹)ÇÇÁö
  • Anterior cutaneous branch
    ¾ÕÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÀüÇÇÁö
  • Anterior cutaneous branches
    ¾ÕÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÀüÇÇÁö
  • Superior lateral cutaneous nerve of arm
    À§°¡ÂÊÀ§ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] »ó¿ÜÃø»ó¿ÏÇǽŰæ
  • Intermediate dorsal cutaneous nerve
    Áß°£¹ßµîÇǺνŰæ
    [¿¾ ¿ë¾î] ÁßÁ·¹èÇǽŰæ
  • Cutaneous branch
    ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÇÇÁö
  • Cutaneous branches
    ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÇÇÁö
  • Cutaneous sulci
    ÇǺΰí¶û
    [¿¾ ¿ë¾î] ÇǺμұ¸
  • Cutaneous muscle
    ÇǺαÙÀ°
    [¿¾ ¿ë¾î] ÇDZÙ
  • Cutaneous ridges
    ÇǺδɼ±
    [¿¾ ¿ë¾î] ÇǺμҸª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PCNA Per-Cutaneous Needle Aspiration of lung
S.C. Sub Cutis; Sub-Cutaneous(ly) injection; ÇÇÇÏ·Î, ÇÇÇÏÁÖ»ç
SCLE Subacute Cutaneous Lupus Erythematosus
BCPV bovine cutaneous papilloma virus
B-K initials of two patients after whom a multiple cutaneous nevus [mole] was named
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FDA Food And Drug Administration
FDAMA Food and Drug Administration Modernization Act of 1997
HCFA Health Care Finance Administration
"HCFA" Health Care Financing Administration
HRSA Health Resources and Services Administration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺαº
  • cutaneous afferent
    ÇǺΠ±¸½É ½Å°æ
  • cutaneous artery
    ÇǺΠµ¿¸Æ
  • cutaneous B cell lymphoma
    ÇǺΠB ¼¼Æ÷ ¸²ÇÁÁ¾
  • cutaneous burn
    ÇǺΠȭ»ó
  • cutaneous circulation
    ÇǺΠ¼øÈ¯
  • cutaneous gland
    ÇǺΠ¼±
  • cutaneous hyperactivity
    ÇǺΠ°ú¹Î ¹ÝÀÀ
  • cutaneous hypersensitivity
    ÇǺΠ°ú¹ÎÁõ
  • cutaneous lupus erythematosus
    ÇǺΠȫ¹Ý¼º ·çÇÁ½º
  • cutaneous lymphoblastoma
    ÇǺΠ¸²ÇÁ¾Æ¼¼Æ÷Á¾
  • cutaneous manifestation
    ÇǺΠÁõ»ó ¹× ¡ÈÄ
  • cutaneous metastatic carcinoma
    ÇǺΠÀüÀÌ ¾Ï, ÇǺΠÀüÀÌ ¾ÏÁ¾
  • cutaneous myxoid cyst
    ÇǺΠÁ¡¾×¾ç ³¶Á¾
  • cutaneous nerve
    ÇǺΠ½Å°æ, ÇÇ ½Å°æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
self administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.
(12 Dec 1998)
hospital administration Management of the internal organization of the hospital.
(12 Dec 1998)
nursing administration research research concerned with establishing costs of nursing care, examining the relationships between nursing services and quality patient care, and viewing problems of nursing service delivery within the broader context of policy analysis and delivery of health services
(12 Dec 1998)
drug administration routes The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.
(12 Dec 1998)
drug administration schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
(12 Dec 1998)
occupational safety and health administration One of the U.S. Agencies responsible for regulation of biotechnology. The major law under which the agency has regulatory powers is the Occupational Safety and Health act.
(09 Oct 1997)
organization and administration The planning and managing of programs, services, and resources.
(12 Dec 1998)
united states food and drug administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
(12 Dec 1998)
united states health care financing administration A component of the department of health and human services to oversee and direct the medicare and medicaid programs and related federal medical care quality control staffs.
(12 Dec 1998)
united states health resources and services administration A component of the public health service that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.
(12 Dec 1998)
united states national aeronautics and space administration An independent federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles.
(12 Dec 1998)
united states occupational safety and health administration An office in the department of labour responsible for developing and establishing occupational safety and health standards.
(12 Dec 1998)
united states social security administration The social security administration administers a national program of contributory social insurance whereby employees, employers, and the self-employed pay contributions that are pooled in special trust funds. When earnings are reduced because of retirement, death, or disability, monthly benefits are paid to partially replace lost earnings. Part of the contributions go into a separate hospital insurance trust fund for workers when they become 65 to provide help with medical expenses. Other programs include the supplemental social security income program for the aged, blind, and disabled and the old age survivors and disability insurance program. Ssa became an independent agency march 31, 1995. It had previously been part of the department of health, education, and welfare, later the department of health and human services.
(12 Dec 1998)
united states substance abuse and mental health services administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym samhsa. On 1 october 1992, the united states alcohol, drug abuse, and mental health administration (adamha) became samhsa. (telephone communication with samhsa 7 april 1992)
(12 Dec 1998)
food and drug administration The U.S. Agency responsible for regulation of biotechnology foodproducts. The major laws under which the agency has regulatory powersinclude the Food, Drug, and Cosmetic act, and the Public Health Service Act.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á